Clinical Trial Update: Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

View source ↗

Summary

Clinical trial update showing ongoing recruitment for a study evaluating whether fat-free mass-based carboplatin dosing affects chemotherapy toxicity in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Lung Cancer, Sarcopenia | Status: RECRUITING